Investment Firm ADIA Sets to Infuse USD 200 Million into Meril
Meril, an Indian medical devices company founded by the Bilakhia Group, has secured a significant investment of USD 200 million from the Abu Dhabi Investment Authority (ADIA). This investment comes as part of ADIA's strategy to focus on long-term value creation.
The investment, which values Meril at an enterprise value of USD 6.6 billion, has also been backed by Warburg Pincus, a US private equity firm. Warburg Pincus had already invested USD 210 million in Meril in 2022, marking an earlier minority stake.
Meril is committed to becoming the world's leading MedTech company, powered entirely by green energy. The company's dedication to sustainability, quality, and global impact is evident in its robust in-house global R&D ecosystem and its portfolio of over 200 technology platforms.
The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Once approved, the investment will enable Meril to accelerate growth, attract world-class talent, and further strengthen its R&D and clinical research efforts.
Headquartered in Vapi, India, Meril operates state-of-the-art, vertically integrated, and globally certified manufacturing and R&D facilities. The company is a global innovator in medical technology (MedTech) with a focus on clinically advanced solutions across multiple specialties.
Through its 12+ global training academies, Meril empowers over 10,000 healthcare professionals annually. The company leads in global clinical research and education, with breakthrough innovations such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System.
Meril develops clinically meaningful products across cardiovascular, orthopaedic, diagnostic, Endo-Surgery, and robotic surgery domains. The company employs more than 13,000 people, has 35+ global subsidiaries, and serves healthcare systems in 150+ countries.
For more information about Meril, visit www.merillife.com. For more information about ADIA, visit www.adia.ae.
[1] Meril Life [2] Abu Dhabi Investment Authority [3] Business Standard [4] The Economic Times
- The Abu Dhabi Investment Authority's focus on long-term value creation has led to a significant USD 200 million investment in Meril Life, an Indian medical devices company, bringing its enterprise value to USD 6.6 billion.
- Notably, this investment, backed by Warburg Pincus, a US private equity firm, aligns with Meril Life's goal of becoming the world's leading MedTech company powered entirely by green energy.
- With its commitment to innovation, education, and health-and-wellness, Meril Life has developed clinically meaningful products across various domains like cardiovascular, orthopaedic, diagnostic, Endo-Surgery, and robotic surgery.
- As Meril Life aims to attract world-class talent, further strengthen its R&D and clinical research efforts, and accelerate growth, this investment from ADIA will provide a substantial boost to finance these ambitious endeavors in healthcare technology, science, and sustainability.
